NeuroDex
PrivateLast Round
Grant
Nov 6, 2024
Total Funding Raised
$1.55M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NeuroDex is a biotechnology company that has developed a blood-based diagnostics platform designed to diagnose neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroDex Comparables
Compare NeuroDex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoSomiX, Inc. | 90% | |
| C₂N Diagnostics | 79% | |
| Amydis, Inc. | 78% | |
NeuroDex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 6, 2024 | ||||
| Grant | Nov 1, 2024 | ||||
| Grant | Oct 31, 2023 | ||||
| Grant | Mar 28, 2023 | ||||
| Grant | Jan 26, 2023 | ||||
Seed | Aug 16, 2022 |
NeuroDex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Target ALS | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| ICV Venture Engineering Fund I | Seed |
| Alzheimer's Drug Discovery Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 56% MoM.
- Apr 22, 2026
Monthly visitors increased 251% MoM.
NeuroDex Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroDex's valuation, stock price, and market status.